|
|
|
|
LEADER |
03726nma a2200889 u 4500 |
001 |
EB002194235 |
003 |
EBX01000000000000001331700 |
005 |
00000000000000.0 |
007 |
cr||||||||||||||||||||| |
008 |
240202 ||| eng |
020 |
|
|
|a 9783036591667
|
020 |
|
|
|a books978-3-0365-9167-4
|
020 |
|
|
|a 9783036591674
|
100 |
1 |
|
|a Li, Dehai
|
245 |
0 |
0 |
|a Diversity of Marine Fungi as a Source of Bioactive Natural Products
|h Elektronische Ressource
|
260 |
|
|
|a Basel
|b MDPI - Multidisciplinary Digital Publishing Institute
|c 2023
|
300 |
|
|
|a 1 electronic resource (188 p.)
|
653 |
|
|
|a gene knockout
|
653 |
|
|
|a cell cycle
|
653 |
|
|
|a combination analysis
|
653 |
|
|
|a terrein
|
653 |
|
|
|a gemcitabine
|
653 |
|
|
|a marine-derived fungus
|
653 |
|
|
|a psychrophilic fungus
|
653 |
|
|
|a Simplicillium lamellicola
|
653 |
|
|
|a marine Aspergillus
|
653 |
|
|
|a Penicillium sp.
|
653 |
|
|
|a arctic fungus
|
653 |
|
|
|a N-OH glycine
|
653 |
|
|
|a polyketides
|
653 |
|
|
|a biosynthesis
|
653 |
|
|
|a molecular docking
|
653 |
|
|
|a immunosuppressive activity
|
653 |
|
|
|a Pharmacology / bicssc
|
653 |
|
|
|a bergamotanes
|
653 |
|
|
|a secondary metabolites
|
653 |
|
|
|a silent gene clusters
|
653 |
|
|
|a apoptosis
|
653 |
|
|
|a nicotinic acetylcholine receptors
|
653 |
|
|
|a nonreducing polyketide synthase (nrPKS)
|
653 |
|
|
|a colorectal cancer
|
653 |
|
|
|a marine
|
653 |
|
|
|a cycloheptapeptide
|
653 |
|
|
|a andrastin-type meroterpenoids
|
653 |
|
|
|a isocoumarins
|
653 |
|
|
|a drimane sesquiterpenoid
|
653 |
|
|
|a heterologous expression
|
653 |
|
|
|a solid-phase synthesis
|
653 |
|
|
|a fungi
|
653 |
|
|
|a tetrahydropyridoindoles unit
|
653 |
|
|
|a tetrapeptides
|
653 |
|
|
|a cytosporin
|
653 |
|
|
|a genome mining
|
653 |
|
|
|a MATRIX
|
653 |
|
|
|a autophagy
|
653 |
|
|
|a GNPS molecular networking
|
653 |
|
|
|a Eutypella sp.
|
653 |
|
|
|a sesquiterpenoids
|
653 |
|
|
|a antimicrobials activities
|
653 |
|
|
|a biological activities
|
653 |
|
|
|a Medicine and Nursing / bicssc
|
653 |
|
|
|a talarolides
|
653 |
|
|
|a anti-inflammatory activity
|
653 |
|
|
|a qPCR
|
653 |
|
|
|a Talaromyces
|
653 |
|
|
|a metabolomics
|
653 |
|
|
|a antimicrobial activity
|
700 |
1 |
|
|a Li, Dehai
|
041 |
0 |
7 |
|a eng
|2 ISO 639-2
|
989 |
|
|
|b DOAB
|a Directory of Open Access Books
|
500 |
|
|
|a Creative Commons (cc), https://creativecommons.org/licenses/by/4.0/
|
024 |
8 |
|
|a 10.3390/books978-3-0365-9167-4
|
856 |
4 |
0 |
|u https://www.mdpi.com/books/pdfview/book/8087
|7 0
|x Verlag
|3 Volltext
|
856 |
4 |
2 |
|u https://directory.doabooks.org/handle/20.500.12854/128635
|z DOAB: description of the publication
|
082 |
0 |
|
|a 610
|
082 |
0 |
|
|a 615
|
520 |
|
|
|a Bioactive metabolites from marine-derived fungi are known to be an important source of drug discoveries. Natural product scientists have explored various environments, such as the deep ocean and polar regions, as well as marine mangrove ecosystems, to discover unique fungi strains which could produce new bioactive structures. The aim of this Special Issue is to highlight the diversity of fungi derived from different marine environments, as well as their potential as producers of bioactive marine natural products. Innovative scientific results, as well as approaches and methodologies applied in marine natural product discovery areas, are encouraged. Studies on the biosynthesis and bioactivities of marine natural products are also welcome. For this Special Issue, we invited academic and industry scientists to submit reviews and original and conceptual research articles highlighting diversified marine fungi as a source of bioactive natural products.
|